G

S

GEYL , Sophie

Last name: GEYL

First name: Sophie

2022 (v1)

Journal article

Metadata-only

Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: A GETAID multicentre cohort study

Fumery, Mathurin Defrance, Antoine Roblin, Xavier

Background: Phase III trials have demonstrated the efficacy of risankizumab in moderate-to-severe Crohn's disease (CD), but no real-world data are currently available. We aimed to assess the short-term effectiveness and safety of risankizumab in patients with CD.Methods: From May 2021 to May 2022, all patients with refractory luminal CD treated...

Uploaded on: February 22, 2023